Dr. Johnson specializes in Interventional Cardiology, Vascular Medicine, Cardiovascular Disease and Endovascular Medicine.
Dr. Roffman specializes in Cardiovascular Disease.
Dr. Kruger obtained her medical degree from The University of Medicine and Pharmacy in Cluj-Napoca, Romania. She completed her Fellowship in General and Interventional Cardiology at Saint Vincent Hospital in Worcester, Massachusetts. She is Board Certified in Cardiovascular Disease, Nuclear Cardiology, and Echocardiography. Dr. Kruger is interested in all aspects of general and interventional cardiology, with a focus on transradial cardiac catheterization and intervention. Dr. Kruger is married and has two young sons. She speaks fluent Spanish and conversational French and Italian.
Dr. Rahimizadeh specializes in Cardiovascular Disease.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
More than one-in-three patients with atrial fibrillation (AFib), or irregular heartbeat, with an intermediate-to-high-risk of stroke are prescribed aspirin instead of oral anticoagulants, despite guidelines recommending the use of oral anticoagulants for this group of patients, according to a study published in the Journal of the American College of Cardiology.
Novel cardiovascular disease risk factors improved in adolescents after 2 weeks of high-intensity interval training, according to data published in the American Journal of Physiology - Heart and Circulatory Physiology. Source: Healio Read More Read More
The formation of blood clots in the veins known as venous thromboembolism is the most common cause of preventable death in hospitals. A new study has now revealed that significant numbers of patients are not receiving recommended treatment to prevent these clots from forming - even after health care providers underwent educational programs. Source: Medical News Today Read More Read More
The U.S. Food and Drug Administration has approved the VenaSeal closure system (VenaSeal system) to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive agent. Source: Medical News Today Read More Read More
A new clinical prediction model can help identify high risk of venous thromboembolism (VTE) among patients with a leg cast, according to a study published this week in PLOS Medicine. The study was conducted by Banne Nemeth of Leiden University Medical Center in the Netherlands, and colleagues and utilized data from three large cohorts to develop and validate two prediction models and a risk score, the L-TRiP(cast) score, to help doctors deciding whether to prescribe anticoagulants for thromboprophylaxis. Source: Medical News Today Read More Read More